scispace - formally typeset
Journal ArticleDOI

Screening for colorectal cancer

Peter C Gøtzsche
- 01 Feb 1997 - 
- Vol. 349, Iss: 9048, pp 356
About
This article is published in The Lancet.The article was published on 1997-02-01. It has received 11 citations till now. The article focuses on the topics: Cancer & Epidemiology of cancer.

read more

Citations
More filters
Journal ArticleDOI

The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.

TL;DR: Four liquid biosources, tumor-educated platelets (TEPs), cell-free DNA (cfDNA), circulating tumor cells (CTCs), and extracellular vesicles (EVs) are reviewed and their optimal application in non-small cell lung cancer diagnosis and therapy is clarified.
Book ChapterDOI

The Impact of Mammography Screening on the Diagnosis and Management of Early-Phase Breast Cancer

TL;DR: This chapter provides a comprehensive review of the conflicting theories concerning better control of breast cancer and suggests that adding the mammographic tumor features to the current histologic prognostic features improves the prediction of long-term patient outcome and facilitates treatment planning.
Journal ArticleDOI

Hemoccult should no longer be used for the screening of colorectal cancer

TL;DR: Reduced mortality in the annually screened group was accompanied by improved survival and a shift to detection at an earlier stage of cancer, which was similar to that of the patients in the control group.
Journal ArticleDOI

Cancer mortality in the 50 - 69 year age group before and after screening

TL;DR: It is believed that Tabár founded Mammography Education Inc, Arizona in 1980, which still exists, and in 1999, he declared an income of five million SEK in Sweden, which is an extraordinary amount according to Nordic standards, and an important conflict of interest should be declared.
References
More filters
Journal ArticleDOI

Randomised controlled trial of faecal-occult-blood screening for colorectal cancer

TL;DR: Evidence from this study and other trials suggest that consideration should be given to a national programme of FOB screening to reduce CRC mortality in the general population.
Journal ArticleDOI

Randomised study of screening for colorectal cancer with faecal-occult-blood test

TL;DR: The findings indicate that biennial screening by FOB tests can reduce CRC mortality, and the effect of the removal of more precursor adenomas in the screening-group participants than in controls on CRC incidence.